Literature DB >> 33984150

Converging evidence for inhibition of transcriptional control in high-grade gliomas.

Nathan A Dahl1,2, Rajeev Vibhakar1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33984150      PMCID： PMC8328005          DOI： 10.1093/neuonc/noab112

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.

Authors:  Kazuya Fukasawa; Takuya Kadota; Tetsuhiro Horie; Kazuya Tokumura; Ryuichi Terada; Yuka Kitaguchi; Gyujin Park; Shinsuke Ochiai; Sayuki Iwahashi; Yasuka Okayama; Manami Hiraiwa; Takanori Yamada; Takashi Iezaki; Katsuyuki Kaneda; Megumi Yamamoto; Tatsuya Kitao; Hiroaki Shirahase; Masaharu Hazawa; Richard W Wong; Tomoki Todo; Atsushi Hirao; Eiichi Hinoi
Journal:  Oncogene       Date:  2021-03-16       Impact factor: 9.867

2.  RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.

Authors:  Qi Xie; Qiulian Wu; Leo Kim; Tyler E Miller; Brian B Liau; Stephen C Mack; Kailin Yang; Daniel C Factor; Xiaoguang Fang; Zhi Huang; Wenchao Zhou; Kareem Alazem; Xiuxing Wang; Bradley E Bernstein; Shideng Bao; Jeremy N Rich
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

3.  Novel Targeting of Transcription and Metabolism in Glioblastoma.

Authors:  Yu-Ting Su; Robert Chen; Herui Wang; Hua Song; Qi Zhang; Li-Yuan Chen; Hallie Lappin; Gabriel Vasconcelos; Adrian Lita; Dragan Maric; Aiguo Li; Orieta Celiku; Wei Zhang; Kristan Meetze; Thomas Estok; Mioara Larion; Mones Abu-Asab; Zhengping Zhuang; Chunzhang Yang; Mark R Gilbert; Jing Wu
Journal:  Clin Cancer Res       Date:  2017-12-18       Impact factor: 12.531

4.  Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.

Authors:  Emilie Le Rhun; Caroline von Achenbach; Birthe Lohmann; Manuela Silginer; Hannah Schneider; Kristan Meetze; Emese Szabo; Michael Weller
Journal:  Int J Cancer       Date:  2019-01-12       Impact factor: 7.396

5.  Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.

Authors:  Surya Nagaraja; Nicholas A Vitanza; Pamelyn J Woo; Kathryn R Taylor; Fang Liu; Lei Zhang; Meng Li; Wei Meng; Anitha Ponnuswami; Wenchao Sun; Jie Ma; Esther Hulleman; Tomek Swigut; Joanna Wysocka; Yujie Tang; Michelle Monje
Journal:  Cancer Cell       Date:  2017-04-20       Impact factor: 31.743

6.  Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma.

Authors:  Nathan A Dahl; Etienne Danis; Ilango Balakrishnan; Dong Wang; Angela Pierce; Faye M Walker; Ahmed Gilani; Natalie J Serkova; Krishna Madhavan; Susan Fosmire; Adam L Green; Nicholas K Foreman; Sujatha Venkataraman; Rajeev Vibhakar
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

7.  Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.

Authors:  S A Greenall; Y C Lim; C B Mitchell; K S Ensbey; B W Stringer; A L Wilding; G M O'Neill; K L McDonald; D J Gough; B W Day; T G Johns
Journal:  Oncogenesis       Date:  2017-05-15       Impact factor: 7.485

8.  CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo.

Authors:  Wei Meng; Jiajia Wang; Baocheng Wang; Fang Liu; Meng Li; Yang Zhao; Chenran Zhang; Qifeng Li; Juxiang Chen; Liye Zhang; Yujie Tang; Jie Ma
Journal:  Cancer Manag Res       Date:  2018-11-15       Impact factor: 3.989

9.  Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.

Authors:  Hiroaki Katagi; Nozomu Takata; Yuki Aoi; Yongzhan Zhang; Emily J Rendleman; Gavin T Blyth; Frank D Eckerdt; Yusuke Tomita; Takahiro Sasaki; Amanda M Saratsis; Akihide Kondo; Stewart Goldman; Oren J Becher; Edwin Smith; Lihua Zou; Ali Shilatifard; Rintaro Hashizume
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

10.  Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.

Authors:  Tyler E Miller; Brian B Liau; Lisa C Wallace; Andrew R Morton; Qi Xie; Deobrat Dixit; Daniel C Factor; Leo J Y Kim; James J Morrow; Qiulian Wu; Stephen C Mack; Christopher G Hubert; Shawn M Gillespie; William A Flavahan; Thomas Hoffmann; Rohit Thummalapalli; Michael T Hemann; Patrick J Paddison; Craig M Horbinski; Johannes Zuber; Peter C Scacheri; Bradley E Bernstein; Paul J Tesar; Jeremy N Rich
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.